Status: current, Primitive. Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3973908017 | Sacituzumab govitecan | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3973909013 | Sacituzumab govitecan (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sacituzumab govitecan | Has disposition | Topoisomerase inhibitor | true | Inferred relationship | Some | ||
| Sacituzumab govitecan | Is a | Topoisomerase inhibitor | true | Inferred relationship | Some | ||
| Sacituzumab govitecan | Is modification of | Sacituzumab | false | Inferred relationship | Some | ||
| Sacituzumab govitecan | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Sacituzumab govitecan | Is a | Enzyme inhibitor protein | true | Inferred relationship | Some | ||
| Sacituzumab govitecan | Is a | Antineoplastic agent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sacituzumab govitecan-containing product | Has active ingredient | True | Sacituzumab govitecan | Inferred relationship | Some | 1 |
| Sacituzumab govitecan only product | Has active ingredient | True | Sacituzumab govitecan | Inferred relationship | Some | 1 |
| Sacituzumab govitecan-containing product in parenteral dose form | Has active ingredient | True | Sacituzumab govitecan | Inferred relationship | Some | 1 |
| Sacituzumab govitecan only product in parenteral dose form | Has active ingredient | True | Sacituzumab govitecan | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR